Prothena Corporation plc (PRTA)
NASDAQ: PRTA · Real-Time Price · USD
8.67
+0.03 (0.35%)
At close: Feb 27, 2026, 4:00 PM EST
9.15
+0.48 (5.54%)
After-hours: Feb 27, 2026, 7:54 PM EST
Prothena Corporation Market Cap
Prothena Corporation has a market cap or net worth of $466.73 million as of February 27, 2026. Its market cap has decreased by -37.23% in one year.
Market Cap
466.73M
Enterprise Value
167.57M
1-Year Change
-37.23%
Ranking
Category
Stock Price
$8.67
Market Cap Chart
Since December 21, 2012, Prothena Corporation's market cap has increased from $127.30M to $466.73M, an increase of 266.64%. That is a compound annual growth rate of 10.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 466.70M | -9.22% |
| Dec 31, 2025 | 514.10M | -31.02% |
| Dec 31, 2024 | 745.30M | -61.78% |
| Dec 29, 2023 | 1.95B | -33.09% |
| Dec 30, 2022 | 2.91B | 26.63% |
| Dec 31, 2021 | 2.30B | 380.02% |
| Dec 31, 2020 | 479.50M | -24.08% |
| Dec 31, 2019 | 631.60M | 53.82% |
| Dec 31, 2018 | 410.60M | -71.51% |
| Dec 29, 2017 | 1.44B | -15.04% |
| Dec 30, 2016 | 1.70B | -20.98% |
| Dec 31, 2015 | 2.15B | 277.66% |
| Dec 31, 2014 | 568.50M | -1.92% |
| Dec 31, 2013 | 579.60M | 347.22% |
| Dec 31, 2012 | 129.60M | 1.81% |
View and export this data all the way back to 2012.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Invivyd | 477.97M |
| Solid Biosciences | 476.03M |
| Lyell Immunopharma | 474.17M |
| Larimar Therapeutics | 471.60M |
| Rocket Pharmaceuticals | 469.68M |
| vTv Therapeutics | 466.76M |
| Lineage Cell Therapeutics | 465.27M |
| Assembly Biosciences | 462.02M |